|
Pharmacy Benefits Management Services
|
Drug Monographs
The purpose of VACO PBM-SHG drug monographs is to provide a comprehensive drug review for making formulary decisions. These documents will be updated when new data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current.
| Abatacept, Monograph |
| Acamprosate, Monograph & Addendum |
| Adalimumab, Monograph |
| Adefovir Monograph Adefovir Addendum |
| Agalsidase Monograph |
| Alefacept, Monograph |
| Alemtuzumab Monograph |
| Alfuzosin, Monograph |
| Aliskiren, Monograph |
| Ambrisentan, Monograph |
| Anidfulafungin (Eraxis), Monograph |
| Apomorphine, Monograph |
| Aprepitant Monograph |
| Arformoterol Monograph |
| Aripiprazole Monograph |
| Aripiprazole IM Monograph |
| Atomoxetine Monograph |
| Azacitidine Monograph |
| Azithromycin Monograph |
| Bevacizumab, Monograph |
| Bortezomib, Monograph |
| Bromfenac 0.09% Ophthalmic Solution , Monograph |
| Buprenorphine Pharmacist Information BuprenorphineDrug Monograph |
| Cetuximab, Monograph |
| Cilostazol, Monograph |
| Cinacalcet, Monograph |
| Conivaptan, Monograph |
| Daptomycin Monograph |
| UNDER REVISION for Oncology data DarbepoetinMonograph |
| Darunavir, Monograph |
| Dasatinib, Monograph |
| Decitabine, Monograph |
| Desloratadine Monograph |
| Duloxetine(Pain) Duloxetine(Antidepressant) Monograph |
| Dutasteride Monograph |
| Efalizumab, Monograph |
| Efavirenz, Emtricitabine, And Tenofovir (Atripla), Monograph |
| Emtricitabine, Monograph |
| Entecavir, Monograph |
| Epinastine, Monograph |
| Eplerenone, Monograph |
| Erlotinib, Monograph |
| ErtapenemMonograph |
| Escitalopram2 Monograph |
| Eszopiclone, Monograph |
| Etravirine, Monograph |
| Exenatide, Monograph |
| Ezetimibe Monograph Ezetimibe Addendum |
Fondaparinux Monograph
Fondaparinux Addendum
Fondaparinux Drug Monograph 2nd Addendum |
| Formoterol Nebulizer Solution, Monograph |
| Fulvestrant, Monograph |
| Quadrivalent HPV vaccine (Gardasil) Monograph |
| Ibandronate Monograph |
| Gefitinib Monograph |
| Hyaluronidase (Amphadase, Hydase, Vitrase, Hylenex) Monograph |
| IIoprost, Monograph |
| Imatinib Monograph Imatinib Addendum |
| Insulin Detemir Monograph |
| Isosorbide Dinitrate/Hydralazine Fixed-Dose Combination Monograph |
| Lanthanum Carbonate,Monographs |
| Laronidase, Monograph |
| Lenalidomide, Monograph |
| Lovaza (formerly Omacor),, Monograph |
| Lubiprostone, Monograph |
| Maraviroc, Monograph |
| Micafungin, Monograph |
| Micafungin (addendum), Monograph.doc |
| Memantine, Monograph |
| Mometasone, Monograph |
| Mycophenolate Sodium (Myfortic), Monograph |
| Nebivolol, Monograph |
| Nelarabine, Monograph |
| Nepafenac, Monograph |
| Nesiritide Monograph Nesiritide Addendum |
| Nitazoxanide Monograph |
| Factor VII, Recombinant Activated (Novoseven®) Monograph |
| Ocuvite, Monograph |
| Olanzapine IM Monograph |
| Omacor Monograph |
| Orlistat, Monograph |
| Oseltamivir Monograph |
| Oxaliplatin Monograph OxaliplatinAddendum |
| Paliperidone, Monograph |
| Panitumumab, Monograph |
| Papain Urea, Monograph |
| Paricalcitol, Monograph |
| Pegaptanib, Monograph |
| Peginterferon Monograph |
| Pegvisomant Monograph |
| Pegylated Interferon Notice to Hepatitis C Clinicians |
| Pemetrexed, Monograph |
| Posaconazole, Monograph |
| Pramlintide, Monograph |
| Pregabalin, Monograph |
| Raltegravir, Monograph |
| Ramelteon, Monograph |
| Ranibizumab, Monograph |
| Ranolazine Monograph |
| Rasagiline, Monograph |
| Retapamulin (Altabax), Monograph |
| Rifaximin, Monograph |
| Risperidone,Monograph |
| Ropinirole Monograph |
| Rosuvastatin Monograph |
| Selegiline Transdermal System (EMSAM) Monograph |
| Sertaconzole, Monograph |
| Sibutramine, Monograph |
| Sirolimus Monograph |
| Sitagliptin Monograph |
| Sorafenib Monograph |
| Sunitinib Monograph |
| Telbivudine Monograph |
| Teriparatide, Monograph |
| Tetanus-Diptheria-Pertussis (Tdap) Vaccine, Monograph |
| Tigecycline (Tygacil), Monograph |
| Tiotropium, Monograph |
| Tipranavir, Monograph |
| Treprostinil Monograph |
| Valdecoxib Monograph |
| Varenicline Monograph |
| Voriconazole Monograph |
| Zemaira, Monograph |
| Ziconotide, Monograph & Ziconotide, Criteria for Non-Formulary Use |
| Ziprasidone IM Monograph |
| Ziprasidone Monograph |
| Zoledronic Acid Monograph |
| Zoledronic Acid (Reclast) Monograph |
| Zoster Vaccine Monograph |
If you have a question pertaining to this website and only information contained in this website, please contact the PBM Webmaster. Please note: For questions pertaining to Health Care Benefits, please visit http://www.va.gov/Health_Benefits/. For questions pertaining to prescription renewal, please visit https://www.myhealth.va.gov/. Questions pertaining to your drug therapy or other medical questions should be referred directly to your Health Care Providers located at the VA facilities where you receive care.
|
|
| Reviewed/Updated Date:
Thursday, January 08, 2009
|
|
